Session 2: Rewards and Challenges of Scale-up and Large Scale Fermentation Processes
Monday, November 9, 2015: 8:00 AM-11:30 AM
Grand Ballroom F-G (Hilton Clearwater Beach Hotel)
Christopher McDowell - Novozymes North America
Dale Brown - Dow AgroSciences LLC and Billy Allen - Eli Lilly and Company

8:00 AM
Modelling large-scale bubble column bioreactors using computational fluid dynamics
D. McClure*, J. Kavanagh, D. Fletcher and G. Barton, The University of Sydney, Sydney
8:25 AM
New approaches to better understanding large scale recombinant protein production
S.M. Stocks* and M. Albaek, Novozymes A/S, Bagsværd, Denmark
8:50 AM
9:20 AM
Life-cycle fossil energy consumption and greenhouse gas emissions of bioderived chemicals and their conventional counterparts
F. Adom*, J. Dunn, H. Jeongwoo and N. Sather, Argonne National Laboratory, Lemont, IL
9:45 AM
A Comparison of High Cell Density Fed-Batch Fermentations Involving Recombinant Escherichia coli, Bacillus subtilis and Corynebacterium glutamicum Under Well-Mixed Small-Scale and Simulated Poorly Mixed Large-Scale Conditions
C. Hewitt*, Aston University, Birmingham; A. Nienow, University of Birmingham, Edgbaston; C. Rielly and W. Olughu, Loughborough University, Loughborough; S.M. Stocks, Novozymes A/S, Bagsværd, Denmark
10:10 AM
Challenges in Live Whole Bacteria Vaccines Development and Manufacturing
L. Chew* and P. Shabram, PaxVax Inc, San Diego, CA; M. Leckenby, PaxVax Berna GmbH, Thörishaus, Switzerland
10:35 AM
Scale-up of Renewable Chemical Manufacturing Processes
J. Zahn*, Dupont Tate & Lyle Bio Products, LLC, Loudon, TN; K.J. Sanford, G. Chotani and N. Danielson, DuPont, Palo Alto, CA
11:00 AM
Lunch break
See more of: Invited Papers